September blogs digest: The future of epigenetic drugs, sepsis, mobile health and more

Not had a chance to read all our posts from September? Here’s a roundup of what you’ve missed…

The future of epigenetic drugs

In recent years, research efforts into epigenetic drugs have grown substantially and pharmaceutical companies are making major investments in this field. Sarah Dowie highlights the ‘Epigenetic Drugs’ series in Clinical Epigenetics, Discussing the current landscape of epigenetic drugs and what the future might hold.

Is SIRS dead? The new definition of sepsis

September was SEPSIS awareness month and to mark it we invited Dr Satoshi Gando, Editor in Chief of Journal of Intensive Care to give us an overview of the recent changes to the SEPSIS definition and the history of systemic inflammatory response syndrome (SIRS).

A new golden era for biostatistics? News from ISCB 2016

The International Society for Computational Biology conference took place in Birmingham this year. In this blog, Emma Cookson reports on the proceedings, covering the themes of the conference and highlights from the main talks.

From bed bugs to the Rio Olympics.

pokemon-1557682_640-300x225Healthcare in your pocket? The mobile phone phenomenon: It’s been predicted that the global revenue from mobile health apps will reach $21.1 billion in 2018. In this blog Allison Cuff explores the growing field of mobile health, covering the diversity of apps available, including this summer’s mobile phenomenon Pokemon Go.

1280px-bed_bug_cimex_lectularius-620x342Bed bugs become a new target of the wonder drug ivermectin: Krisztian Magori give an update on the development of ivermectin, a Nobel Prize winning antiparasitic drug and looks at the next steps in implementing it into bed bug integrated pest management.

peerrevwk-1-620x207Celebrating Peer Review Week at Springer Nature: September saw us celebrate peer review week. In this blog Chief Publishing Officer Steven Inchcoombe kicked off the celebrations and introduced the theme ‘Recognition for Review’.

Injured Olympian or weekend warrior, you can’t rush a return to sports: The Rio Olympics injury-300x214was the biggest event of the summer and over its course we witnessed several shocking injuries. In this blog U.S Olympic team physician Dr. Timothy L. Miller highlights his article on managing stress fractures published in the ‘Injuries in sport’ thematic series, Journal of Orthopaedic Surgery, giving examples of the injuries in the Rio Olympics.

The road to 2025: will a treatment for Alzheimer’s be available? World leaders have committed to the prevention and treatment of Alzheimer’s Disease by 2025. In this blog Dr. Jeffrey Cummings discusses this target, drawing from his recent review in Alzheimer’s Research & Therapy.

Rooted in a changing environment: Christian Matheou discusses the challenges that plants face in a changing in environment and how understanding their plasticity in changing shape can help provide tools for us to guide their development.

Peer review: opting out: As part of peer reviewpaper-300x200 week 2016 BMC Biology Editor, Miranda Robertson, looks at why some academics are taking such extreme lengths as to opt out of peer review altogether and whether as a publisher BioMed Central can offer a less radical solution.

View the latest posts on the Research in progress blog homepage